Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcome-Reference-Cited by-同舟云学术

Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcome

Published:2019-08-05 Issue:4 Volume:187 Page:478-487
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Vannata Barbara¹^ORCID,Conconi Annarita²,Winkler Jonas¹,Cascione Luciano³,Margiotta Casaluci Gloria⁴,Nassi Luca⁴,Moia Riccardo⁴,Pirosa Maria Cristina¹,Moccia Alden A.¹^ORCID,Stathis Anastasios¹,Rossi Davide¹³,Gaidano Gianluca⁴,Zucca Emanuele¹³

Affiliation:

1. Oncology Institute of Southern Switzerland (IOSI) Bellinzona Switzerland

2. Division of Haematology, Department of Internal Medicine Ospedale degli Infermi Biella Italy

3. Institute of Oncology Research (IOR) Bellinzona Switzerland

4. Division of Haematology, Department of Translational Medicine Amedeo Avogadro University of Eastern Piedmont and AOU Maggiore della Carità Novara Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16106

Reference52 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2. Review of survival analyses published in cancer journals

3. Combination chemotherapy in non‐Hodgkin's lymphoma: results of long‐term followup;Anderson T.;Cancer Treatment Reports,1977

4. Non-Hodgkin lymphoma

5. Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey;Frontiers in Oncology;2024-06-24

2. Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma;Discover Oncology;2024-04-05

3. Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcome;Clinical and Experimental Medicine;2024-03-01

4. Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences;Modern Pathology;2023-05

5. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts;Cancer Research and Treatment;2023-01-15